An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes

被引:265
作者
Sweeney, G
Somwar, R
Ramlal, T
Volchuk, A
Ueyama, A
Klip, A
机构
[1] Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada
关键词
D O I
10.1074/jbc.274.15.10071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The precise mechanisms underlying insulin-stimulated glucose transport still require investigation. Here we assessed the effect of SB203580, an inhibitor of the p38 MAP kinase family, on insulin-stimulated glucose transport in 3T3-L1 adipocytes and L6 myotubes, We found that SB203580, but not its inactive analogue (SB202474), prevented insulin-stimulated glucose transport in both cell types with an IC50 similar to that for inhibition of p38 MAP kinase (0.6 mu M). Basal glucose uptake was not affected. Moreover, SB203580 added only during the transport assay did not inhibit basal or insulin-stimulated transport. SB203580 did not inhibit insulin-stimulated translocation of the glucose transporters GLUT1 or GLUT4 in 3T3-L1 adipocytes as assessed by immunoblotting of subcellular fractions or by immunofluorescence of membrane lawns. L6 muscle cells expressing GLUT4 tagged on an extracellular domain with a Myc epitope (GLUT4myc) were used to assess the functional insertion of GLUT4 into the plasma membrane. SB203580 did not affect the insulin-induced gain in GLUT4myc exposure at the cell surface but largely reduced the stimulation of glucose uptake. SB203580 had no effect on insulin-dependent insulin receptor substrate-1 phosphorylation, association of the p85 subunit of phosphatidylinositol 3-kinase with insulin receptor substrate-1, nor on pho sphatidylinositol 3-kinase, Akt1, Akt2, or Akt3 activities in 3T3-L1 adipocytes, In conclusion, in the presence of SB203580, insulin caused normal translocation and cell surface membrane insertion of glucose transporters without stimulating glucose transport. We propose that insulin stimulates two independent signals contributing to stimulation of glucose transport: phosphatidylinositol 3-kinase leads to glucose transporter translocation and a pathway involving p38 MAP kinase leads to activation of the recruited glucose transporter at the membrane.
引用
收藏
页码:10071 / 10078
页数:8
相关论文
共 55 条
  • [1] Mechanism of activation of protein kinase B by insulin and IGF-1
    Alessi, DR
    Andjelkovic, M
    Caudwell, B
    Cron, P
    Morrice, N
    Cohen, P
    Hemmings, BA
    [J]. EMBO JOURNAL, 1996, 15 (23) : 6541 - 6551
  • [2] MODULATION OF THE ACTIVITY OF GLUCOSE TRANSPORTERS (GLUT) IN THE AGED OBESE RAT ADIPOCYTE - SUPPRESSED FUNCTION, BUT ENHANCED INTRINSIC ACTIVITY OF GLUT
    ARMONI, M
    HAREL, C
    BURVIN, R
    KARNIELI, E
    [J]. ENDOCRINOLOGY, 1995, 136 (08) : 3292 - 3298
  • [3] Trafficking of glucose transporters - Signals and mechanisms
    Baldwin, SA
    Barros, LF
    Griffiths, M
    [J]. BIOSCIENCE REPORTS, 1995, 15 (06) : 419 - 426
  • [4] Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells
    Barros, LF
    Young, M
    Saklatvala, J
    Baldwin, SA
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1997, 504 (03): : 517 - 525
  • [5] MECHANISMS OF ADAPTATION OF GLUCOSE TRANSPORTERS TO CHANGES IN THE OXIDATIVE CHAIN OF MUSCLE AND FAT-CELLS
    BASHAN, N
    BURDETT, E
    GUMA, A
    SARGEANT, R
    TUMIATI, L
    LIU, Z
    KLIP, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02): : C430 - C440
  • [6] ACUTE AND LONG-TERM EFFECTS OF INSULIN-LIKE GROWTH FACTOR-I ON GLUCOSE TRANSPORTERS IN MUSCLE-CELLS - TRANSLOCATION AND BIOSYNTHESIS
    BILAN, PJ
    MITSUMOTO, Y
    RAMLAL, T
    KLIP, A
    [J]. FEBS LETTERS, 1992, 298 (2-3) : 285 - 290
  • [7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [8] Insulin increases the association of akt-2 with Glut4-containing vesicles
    Calera, MR
    Martinez, C
    Liu, HZ
    El Jack, AK
    Birnbaum, MJ
    Pilch, PF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (13) : 7201 - 7204
  • [9] Carel K, 1996, DIABETES, V45, P666
  • [10] The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)
    Clerk, A
    Sugden, PH
    [J]. FEBS LETTERS, 1998, 426 (01) : 93 - 96